We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

155 hedge funds and large institutions have $14.9M invested in Definium Therapeutics in 2022 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more call options, than puts

Call options by funds: $1.84M | Put options by funds: $842K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.4% less ownership

Funds ownership: 0.76% → 0.36% (-0.4%)

4% less first-time investments, than exits

New positions opened: 49 | Existing positions closed: 51

3% less funds holding

Funds holding: 159 → 155 (-4)

37% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 41

72% less capital invested

Capital invested by funds: $53.6M → $14.9M (-$38.6M)

Holders
155
Holders Change
-4
Holders Change %
-2.52%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
49
Increased
26
Reduced
41
Closed
51
Calls
$1.84M
Puts
$842K
Net Calls
+$1M
Net Calls Change
-$1.77M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$3.91M
2
E
Ergoteles
New York
+$917K
3
LPL Financial
LPL Financial
California
+$653K
4
Citadel Advisors
Citadel Advisors
Florida
+$457K
5
MFG
Merit Financial Group
Georgia
+$449K

Top Sellers

1
BlackRock
BlackRock
New York
-$13.7M
2
State Street
State Street
Massachusetts
-$4.37M
3
Northern Trust
Northern Trust
Illinois
-$2.52M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.21M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCV
176
Banque Cantonale Vaudoise
Switzerland
– -$1K -51 Closed
1832 Asset Management
177
1832 Asset Management
Ontario, Canada
– -$1K -47 Closed
PK
178
Pflug Koory
Nebraska
– -$1K -35 Closed
GI
179
Gradient Investments
Minnesota
– +$13 +1 New
HS
180
Horan Securities
United States
– +$25 +2 New
AF
181
Advisornet Financial
Minnesota
– +$38 +3 New
CCM
182
Covington Capital Management
California
– +$89 +7 New
CB
183
CNB Bank
Pennsylvania
– +$127 +10 New
CA
184
CoreCap Advisors
Michigan
– +$215 +17 New
GLLW
185
Graves Light Lenhart Wealth
Virginia
– +$240 +19 New
TFGT
186
TS Financial Group (TSFG)
Illinois
– +$316 +25 New
PMFA
187
Plante Moran Financial Advisors
Michigan
– +$455 +36 New
CWP
188
Concord Wealth Partners
Virginia
– +$519 +41 New
WIM
189
Westside Investment Management
California
– +$848 +67 New
AWM
190
Avior Wealth Management
Nebraska
– +$1.19K +94 New
4 5 6 7
8

DFTX Hedge Fund Activity: Q2 2022 in Review

155 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2022, worth a combined $14.9M — down 72% from $53.6M a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of DFTX and 49 opened new positions — a net loss of 2 holders — while 41 trimmed existing stakes and 26 added.

The largest buyer was Millennium Management, adding an estimated $3.91M. The largest seller was BlackRock, cutting an estimated $13.7M.

  • 155 institutional investors held Definium Therapeutics (DFTX) as of Q2 2022, down from 159 in Q1 2022.
  • Funds reported $14.9M of Definium Therapeutics stock for Q2 2022, down 72% quarter-over-quarter.
  • 49 funds opened new Definium Therapeutics positions in Q2 2022 and 51 closed out, a net change of -2 holders.
  • The largest Definium Therapeutics buyer in Q2 2022 was Millennium Management, an estimated $3.91M added.
  • The largest Definium Therapeutics seller in Q2 2022 was BlackRock, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2022.